Core Viewpoint - The strategic partnership between Shandong Wohua Pharmaceutical Technology Co., Ltd. and Beijing Yicongrong Technology Co., Ltd. aims to enhance the application of Wohua's patented product, Shen Zhi Ling Oral Liquid, in the prevention and treatment of Alzheimer's disease, addressing a significant public health challenge in China [1][2]. Group 1: Alzheimer's Disease Context - Alzheimer's disease is identified as the "fourth leading killer" threatening the health of the elderly, with approximately 16.99 million existing patients and 2.91 million new cases annually in China [1]. - About 75% of Alzheimer's patients do not receive timely diagnosis, leading to a heavy caregiving burden on millions of families [1]. Group 2: Product and Market Potential - Shen Zhi Ling Oral Liquid, developed over 20 years, is based on traditional Chinese medicine and consists of ten herbal ingredients, demonstrating a multi-target intervention mechanism that improves memory and cognitive function in Alzheimer's patients [2]. - The aging population in China is expected to expand the patient base for Alzheimer's disease significantly over the next decade, indicating a high certainty of market growth and substantial "stock conversion" potential due to low current diagnosis rates [2]. Group 3: Strategic Collaboration - The collaboration between Wohua and Yicongrong represents an important exploration of innovative pharmaceutical models, integrating research, market, and service to enhance the clinical value of traditional Chinese medicine [2]. - Wohua will leverage its production quality and academic promotion capabilities, while Yicongrong will utilize its channel resources and patient service advantages to ensure precise market coverage and deep penetration [2]. Group 4: Future Growth and Brand Development - Wohua views Shen Zhi Ling Oral Liquid as a new growth engine, aiming for strategic synergy through accumulated resources in cardiovascular and neurology fields, promoting long-term stable growth [3]. - The partnership is seen as a key initiative to connect Wohua's unique products with professional market platforms, revitalizing the brand image of Shen Zhi Ling Oral Liquid [3].